Socioeconomic status and reading outcomes: Neurobiological and behavioral correlates
New Directions for Child and Adolescent Development · 2022-07 · 2022 (183-184) · 57-70
DOI: 10.1002/cad.20475 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New Directions for Child and Adolescent Development, online erschienen am 22.07.2022. Verfasst von Rachel R Romeo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Development and Quantitative Methodology, University of Maryland, College Park, Maryland, USA. Hauptthemen laut MEDLINE: Reading, Social Class. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Development and Quantitative Methodology, University of Maryland, College Park, Maryland, USA.
- Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, Massachusetts, USA.
ORCID-Profile: Rachel R Romeo, Joanna A Christodoulou
Förderung
- NICHD NIH HHS
Zitieren
APA
Romeo, R. R., Uchida, L., & Christodoulou, J. A. (2022). Socioeconomic status and reading outcomes: Neurobiological and behavioral correlates. New Directions for Child and Adolescent Development, 2022(183-184), 57-70. https://doi.org/10.1002/cad.20475
Vancouver
Romeo RR, Uchida L, Christodoulou JA. Socioeconomic status and reading outcomes: Neurobiological and behavioral correlates. New Directions for Child and Adolescent Development. 2022;2022(183-184):57-70. doi:10.1002/cad.20475
BibTeX
@article{Romeo2022,
author = {Romeo, Rachel R and Uchida, Lili and Christodoulou, Joanna A},
title = {Socioeconomic status and reading outcomes: Neurobiological and behavioral correlates},
journal = {New Directions for Child and Adolescent Development},
year = {2022},
volume = {2022},
number = {183-184},
pages = {57--70},
doi = {10.1002/cad.20475}
}
EUVIMED